Cargando…
Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy
BACKGROUND: 5-Aminolevulinic acid (ALA) and its derivatives have been widely used in photodynamic therapy. The main drawback associated with ALA-based photodynamic therapy (ALA-PDT) and ALA fluorescence diagnosis results from the hydrophilic nature of ALA and lack of selectivity for tumor versus non...
Autores principales: | Johnson, Renjith P, Chung, Chung-Wook, Jeong, Young-Il, Kang, Dae Hwan, Suh, Hongsuk, Kim, Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367496/ https://www.ncbi.nlm.nih.gov/pubmed/22679363 http://dx.doi.org/10.2147/IJN.S29582 |
Ejemplares similares
-
Amphiphilic Protoporphyrin IX Derivatives as New Photosensitizing Agents for the Improvement of Photodynamic Therapy
por: Desgranges, Stéphane, et al.
Publicado: (2022) -
In Vitro Comparison of Hypericin and 5-Aminolevulinic Acid-Derived Protoporphyrin IX for Photodynamic Inactivation of Medulloblastoma Cells
por: Ritz, Rainer, et al.
Publicado: (2012) -
An experimental investigation of a novel iron chelating protoporphyrin IX prodrug for the enhancement of photodynamic therapy
por: Anayo, Lizette, et al.
Publicado: (2018) -
Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy
por: Magnussen, Anette, et al.
Publicado: (2021) -
Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response
por: Yang, Xue, et al.
Publicado: (2016)